151 related articles for article (PubMed ID: 8397095)
21. The role of calcium ions in DEAE-dextran-induced stimulation of neutrophil migration.
Elferink JG; de Koster BM
Chem Biol Interact; 1995 Mar; 95(1-2):203-14. PubMed ID: 7697751
[TBL] [Abstract][Full Text] [Related]
22. Involvement of cyclic AMP generation in the inhibition of respiratory burst by 2-phenyl-4-quinolone (YT-1) in rat neutrophils.
Wang JP; Raung SL; Huang LJ; Kuo SC
Biochem Pharmacol; 1998 Dec; 56(11):1505-14. PubMed ID: 9827585
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of human neutrophil function by tolfenamic acid involves inhibition of Ca2+ influx.
Kankaanranta H; Wuorela H; Siltaloppi E; Vuorinen P; Vapaatalo H; Moilanen E
Eur J Pharmacol; 1995 Sep; 291(1):17-25. PubMed ID: 8549643
[TBL] [Abstract][Full Text] [Related]
24. Hemin, a heme oxygenase substrate analog, both inhibits and enhances neutrophil random migration and chemotaxis.
Andersson JA; Uddman R; Cardell LO
Allergy; 2002 Nov; 57(11):1008-12. PubMed ID: 12358996
[TBL] [Abstract][Full Text] [Related]
25. Involvement of cyclic adenosine monophosphate-dependent protein kinase A and pertussis toxin-sensitive G proteins in the migratory response of human CD14+ mononuclear cells to katacalcin.
Kaneider NC; Egger P; Wiedermann FJ; Ritter M; Wöll E; Wiedermann CJ
J Bone Miner Res; 2002 Oct; 17(10):1872-82. PubMed ID: 12369791
[TBL] [Abstract][Full Text] [Related]
26. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase.
Wright CD; Kuipers PJ; Kobylarz-Singer D; Devall LJ; Klinkefus BA; Weishaar RE
Biochem Pharmacol; 1990 Aug; 40(4):699-707. PubMed ID: 1696820
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of chemoattractant-induced superoxide formation in human neutrophils by cell-permeant analogues of cyclic AMP and cyclic GMP.
Ervens J; Schultz G; Seifert R
Biochem Soc Trans; 1991 Feb; 19(1):59-63. PubMed ID: 1645316
[No Abstract] [Full Text] [Related]
28. Ryanodine as inhibitor of chemotactic peptide-induced chemotaxis in human neutrophils.
Elferink JG; De Koster BM
Biochem Pharmacol; 1995 Sep; 50(7):975-9. PubMed ID: 7575682
[TBL] [Abstract][Full Text] [Related]
29. Involvement of intracellular cyclic GMP and cyclic GMP-dependent protein kinase in alpha-elastin-induced macrophage chemotaxis.
Kamisato S; Uemura Y; Takami N; Okamoto K
J Biochem; 1997 May; 121(5):862-7. PubMed ID: 9192726
[TBL] [Abstract][Full Text] [Related]
30. The role of cyclic nucleotides in neutrophil migration.
Elferink JG; VanUffelen BE
Gen Pharmacol; 1996 Mar; 27(2):387-93. PubMed ID: 8919662
[TBL] [Abstract][Full Text] [Related]
31. Glutathione-induced enhancement of neutrophil locomotion.
Elferink JG; de Koster BM
Immunobiology; 1991 Dec; 184(1):25-36. PubMed ID: 1666059
[TBL] [Abstract][Full Text] [Related]
32. Vimentin is transiently co-localized with and phosphorylated by cyclic GMP-dependent protein kinase in formyl-peptide-stimulated neutrophils.
Wyatt TA; Lincoln TM; Pryzwansky KB
J Biol Chem; 1991 Nov; 266(31):21274-80. PubMed ID: 1657955
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of interleukin-8-activated human neutrophil chemotaxis by thapsigargin in a calcium- and cyclic AMP-dependent way.
Elferink JG; de Koster BM
Biochem Pharmacol; 2000 Feb; 59(4):369-75. PubMed ID: 10644044
[TBL] [Abstract][Full Text] [Related]
34. S-carboxymethylcysteine inhibits neutrophil activation mediated by N-formyl-methionyl-leucyl-phenylalanine.
Ishii Y; Kimura T; Morishima Y; Mochizuki M; Nomura A; Sakamoto T; Uchida Y; Sekizawa K
Eur J Pharmacol; 2002 Aug; 449(1-2):183-9. PubMed ID: 12163123
[TBL] [Abstract][Full Text] [Related]
35. Dissociation of the PAF-receptor from NADPH oxidase and adenylate cyclase in human neutrophils results in accelerated influx and delayed clearance of cytosolic calcium.
Steel HC; Anderson R
Br J Pharmacol; 2002 May; 136(1):81-9. PubMed ID: 11976271
[TBL] [Abstract][Full Text] [Related]
36. Cyclic GMP mediates SIN-1-induced inhibition of human polymorphonuclear leukocytes.
Schröder H; Ney P; Woditsch I; Schrör K
Eur J Pharmacol; 1990 Jul; 182(2):211-8. PubMed ID: 1697805
[TBL] [Abstract][Full Text] [Related]
37. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
38. Protective effect of indomethacin against chemotactic deactivation of human neutrophils induced by formylated peptide.
Perianin A; Gaudry M; Marquetty C; Giroud JP; Hakim J
Biochem Pharmacol; 1988 May; 37(9):1693-8. PubMed ID: 2837237
[TBL] [Abstract][Full Text] [Related]
39. Involvement of intracellular Ca2+ in chemotaxis and metabolic burst by neutrophils: the use of antagonists of intracellular Ca2+.
Elferink JG; Deierkauf M
Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):67-81. PubMed ID: 4081314
[TBL] [Abstract][Full Text] [Related]
40. Investigation of the cellular mechanism of inhibition of formyl-methionyl-leucyl-phenylalanine-induced superoxide anion generation in rat neutrophils by 2-benzyloxybenzaldehyde.
Wang JP; Chang LC; Lin YL; Hsu MF; Chang CY; Huang LJ; Kuo SC
Biochem Pharmacol; 2003 Apr; 65(7):1043-51. PubMed ID: 12663040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
